Pro Medicus Ltd
ASX:PME
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
176.88
330.48
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
PME
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 217.37 AUD,
Pro Medicus Ltd
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Pro Medicus Ltd
PME looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether PME usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Pro Medicus Ltd.
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
|
| JP |
|
M3 Inc
TSE:2413
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
|
| SE |
|
Sectra AB
STO:SECT B
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
|
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Heightened competition from larger healthcare IT players could erode Pro Medicus’s pricing power and disrupt its pipeline of long-term contracts, especially in the heavily contested U.S. hospital market.
Pro Medicus’s cloud-based imaging software offers faster performance and greater scalability than most legacy systems, giving it a strong competitive advantage in winning high-margin, multi-year contracts with top-tier healthcare providers.
Revenue & Expenses Breakdown
Pro Medicus Ltd
Balance Sheet Decomposition
Pro Medicus Ltd
| Current Assets | 280.1m |
| Cash & Short-Term Investments | 209.2m |
| Receivables | 65.5m |
| Other Current Assets | 5.4m |
| Non-Current Assets | 58.6m |
| Long-Term Investments | 7.3m |
| PP&E | 2.8m |
| Intangibles | 20.8m |
| Other Non-Current Assets | 27.7m |
| Current Liabilities | 43.1m |
| Accounts Payable | 1.4m |
| Other Current Liabilities | 41.7m |
| Non-Current Liabilities | 38.6m |
| Long-Term Debt | 1.6m |
| Other Non-Current Liabilities | 37m |
Free Cash Flow Analysis
Pro Medicus Ltd
| AUD | |
| Free Cash Flow | AUD |
Earnings Waterfall
Pro Medicus Ltd
|
Revenue
|
220.5m
AUD
|
|
Cost of Revenue
|
-309k
AUD
|
|
Gross Profit
|
220.2m
AUD
|
|
Operating Expenses
|
-55m
AUD
|
|
Operating Income
|
165.2m
AUD
|
|
Other Expenses
|
-50m
AUD
|
|
Net Income
|
115.2m
AUD
|
PME Profitability Score
Profitability Due Diligence
Pro Medicus Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Pro Medicus Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
PME Solvency Score
Solvency Due Diligence
Pro Medicus Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Pro Medicus Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PME Price Targets Summary
Pro Medicus Ltd
According to Wall Street analysts, the average 1-year price target for
PME
is 333.02 AUD
with a low forecast of 292.9 AUD and a high forecast of 367.5 AUD.
Dividends
Current shareholder yield for
PME is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PME
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 217.37 AUD,
Pro Medicus Ltd
is
hidden
.